Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Guilford Genomic Medicine Initiative Starts

27.08.2004


A landmark program seeking to bring the promise of genetic research into the “real world” is underway with the first DNA samples to be collected next year. The Guilford Genomic Medicine Iniative is a partnership involving Moses Cone Health System, The University of North Carolina at Greensboro and Duke University.

“This project is an excellent example of solid collaboration in search of a greater good,” Dennis Barry, CEO Emeritus, Moses Cone Health System, says. “After a year of intense planning by all three partners, this initiative is ready to move forward in bringing the science of genetic medicine to Guilford County,” said UNCG Chancellor Patricia Sullivan. “The project will help revolutionize the practice of medicine by taking human genomics from the laboratory to medical practice - and our local residents will be among the first to benefit.”

Hiring of 21 new staff members is under way and, when completed, will put staffing at 40 positions. (16 at Duke University and UNCG and eight at Moses Cone Health System.) Starting next year, patients at select Guilford County medical practices who meet certain criteria will be asked to join the effort. If they agree, blood will be drawn and sent to the Duke Center for Human Genetics. Researchers will check the DNA for risk factors for cardiovascular disease, select cancers and genetic differences in the way the patient reacts to medicines (pharmacogenomics). Geneticists from The Institute for Health, Science and Society at UNCG will counsel patients about the results. Pilot medical programs will be started to allow patients and doctors to act on the information.



In the first three years, researchers plan to screen 2,600 people meeting the project’s criteria. Those selected will match the ethnic make-up of Guilford County. "I am very pleased that our delegation came together again this year to support this hugely important project,” Rep. Brad Miller (D-NC) says. “ I believe that this additional funding for the Genomic Medicine project will make Guilford County and the Triad major players in biotechnology for the next generation and beyond."

Miller and Rep. Howard Coble (R-NC) were lead sponsors in the House for this year’s funding. Rep. David Price (D-NC) and Rep. Mel Watt (D-NC) were also project supporters.

This is the second year Congress has approved $3.4 million for the project. The money is coming through the Department of Defense. "We were pleased to obtain the funding for this worthwhile project because it will directly assist Guilford County veterans,” Coble says. “The challenges of developing a genomic medicine program are beyond the mission and capacity of the Department of Defense. The Guilford Genomic Medicine Project is highly applicable, however, to the military population and can serve as a model upon which the Defense Department can build its own genomic medicine program.”

| newswise
Further information:
http://www.uncg.edu/ihs
http://www.chg.duke.edu
http://www.mosescone.com

More articles from Health and Medicine:

nachricht New antibody analysis accelerates rational vaccine design
09.08.2018 | Scripps Research Institute

nachricht Distrust of power influences choice of medical procedures
01.08.2018 | Johannes Gutenberg-Universität Mainz

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Robots as 'pump attendants': TU Graz develops robot-controlled rapid charging system for e-vehicles

Researchers from TU Graz and their industry partners have unveiled a world first: the prototype of a robot-controlled, high-speed combined charging system (CCS) for electric vehicles that enables series charging of cars in various parking positions.

Global demand for electric vehicles is forecast to rise sharply: by 2025, the number of new vehicle registrations is expected to reach 25 million per year....

Im Focus: The “TRiC” to folding actin

Proteins must be folded correctly to fulfill their molecular functions in cells. Molecular assistants called chaperones help proteins exploit their inbuilt folding potential and reach the correct three-dimensional structure. Researchers at the Max Planck Institute of Biochemistry (MPIB) have demonstrated that actin, the most abundant protein in higher developed cells, does not have the inbuilt potential to fold and instead requires special assistance to fold into its active state. The chaperone TRiC uses a previously undescribed mechanism to perform actin folding. The study was recently published in the journal Cell.

Actin is the most abundant protein in highly developed cells and has diverse functions in processes like cell stabilization, cell division and muscle...

Im Focus: Lining up surprising behaviors of superconductor with one of the world's strongest magnets

Scientists have discovered that the electrical resistance of a copper-oxide compound depends on the magnetic field in a very unusual way -- a finding that could help direct the search for materials that can perfectly conduct electricity at room temperatur

What happens when really powerful magnets--capable of producing magnetic fields nearly two million times stronger than Earth's--are applied to materials that...

Im Focus: World record: Fastest 3-D tomographic images at BESSY II

The quality of materials often depends on the manufacturing process. In casting and welding, for example, the rate at which melts solidify and the resulting microstructure of the alloy is important. With metallic foams as well, it depends on exactly how the foaming process takes place. To understand these processes fully requires fast sensing capability. The fastest 3D tomographic images to date have now been achieved at the BESSY II X-ray source operated by the Helmholtz-Zentrum Berlin.

Dr. Francisco Garcia-Moreno and his team have designed a turntable that rotates ultra-stably about its axis at a constant rotational speed. This really depends...

Im Focus: A molecular switch may serve as new target point for cancer and diabetes therapies

If certain signaling cascades are misregulated, diseases like cancer, obesity and diabetes may occur. A mechanism recently discovered by scientists at the Leibniz- Forschungsinstitut für Molekulare Pharmakologie (FMP) in Berlin and at the University of Geneva has a crucial influence on such signaling cascades and may be an important key for the future development of therapies against these diseases. The results of the study have just been published in the prestigious scientific journal 'Molecular Cell'.

Cell growth and cell differentiation as well as the release and efficacy of hormones such as insulin depend on the presence of lipids. Lipids are small...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Within reach of the Universe

08.08.2018 | Event News

A journey through the history of microscopy – new exhibition opens at the MDC

27.07.2018 | Event News

2018 Work Research Conference

25.07.2018 | Event News

 
Latest News

NRL's sun imaging telescopes fly on NASA Parker Solar Probe

13.08.2018 | Physics and Astronomy

UT-ORNL team makes first particle accelerator beam measurement in six dimensions

13.08.2018 | Physics and Astronomy

ASU astrophysicist helps discover that ultrahot planets have starlike atmospheres

13.08.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>